Ann: Trial ready Cannabis Sublingual Wafer Formulation complete, page-11

I have been thinking what the word vertical expansion means for BDA, as anything that is end to end vertically this should deliver significant value long term.

I am in the opinion that BDA should vertically expand into medical cannibas product development and build an inhouse GMP/ISO certified manufacturing facility.

This way BDA can scour the world for partners (ie Linea and others) with exacting standards of cannibis extracts and variants to import and then to progress R&D product development to then distribute via special access scheme.

This proposition will be add significant value to shareholders as the barriers to entry is high and BDA already has the MM import certification from the FDC.

This will differentiate BDA a little further from other MM peers.